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HIV/AIDS After the Crisis: The Evolution of an Epidemic
In the U.S. alone, around 1.2 million people are currently living with HIV, with 14
percent not knowing that they have the virus. Around the world, the number of people with HIV
reaches closer to 38 million. From these statistics, one thing becomes clear: HIV and AIDS is
still a worldwide epidemic that continues to impact many different cultures. In America, trends
in injection drug use, homophobia and transphobia, and lack of access to HIV prevention, testing
and treatment have all contributed to HIV remaining an issue for the past four decades. In
sub-Saharan Africa, AIDS continues to be the leading cause of death. Poverty, inadequate
medical care, and sexual violence cause rapid spread of the virus, and consequently many
children are born with HIV through vertical transmission.
HIV can be traced back to the 1920s, when simian immunodeficiency virus (SIV) was
passed from chimpanzees to humans. In the early 1980s in the U.S., cases of severe immune
deficiency was found to be affecting mostly gay men, injection drug users, and hemophiliacs.
This immunodeficiency was termed “gay-related immunodeficiency” before the CDC officially
used the term AIDS (acquired immunodeficiency syndrome). By the mid-80s, every region in the
world was reporting cases of AIDS. In 1987, zidovudine (AZT) was released as the first
antiretroviral drug to treat HIV. In 1995, the FDA approved highly active antiretroviral treatment
(HAART), which was highly effective in preventing AIDS-related deaths and hospitalizations in
the countries that could afford the treatment. In the 2010s, more than half of the global
population living with HIV were receiving antiretroviral therapy. Most recently, in 2020 the CDC
announced that HIV-related deaths in the U.S. have fallen by half from 2010 to 2017, likely as a
result of early testing and treatment, and helping people with HIV stay on their antiretroviral
treatment.

June of this year marked the 40 year anniversary of AIDS in America. In the last 40
years, great strides have been made in the field of HIV/AIDS. Vaccine trials are ongoing,
although so far results have not been hopeful. A major study that began in 2016, called the
HVTN 702 trial, just recently fell short of expectations. The vaccine was tailored toward the
subtype of HIV found in South Africa, but the trial showed no evidence of efficacy (Cohen,
2020). However, this should not be seen as a failure by any means. The very nature of the virus
and its ability to replicate, mutate, and hide from the immune system makes it almost impossible
to generate an effective vaccine. Researchers continue to investigate the mechanisms of HIV to
determine the best course of action for treatment. Other studies in the HIV Vaccine Trials
Network (HVTN) are still ongoing, so there is still plenty of hope to be had for the future of HIV
vaccines and treatments.
This paper will review the impact of HIV/AIDS in several less-developed countries,
examine how societal aspects of the virus have evolved, and look at current as well as future HIV
treatments. These are key areas that must continue to be studied in order for the virus to be
eradicated. Careful attention must be paid not only to the physical wellbeing of HIV-positive
individuals, but also to their mental state and how they are viewed by society.
Global Impacts of HIV/AIDS
HIV in Asia, Europe, and South America
With all of the stigma and assumptions that are behind HIV/AIDS infection, it’s easy to
see how certain cultures may be less tolerant of the virus and how it is spread. A crucial step in
preventing the spread of HIV is education about safe practices. A study done in Beijing, China
showed that the percentage of college students with comprehensive knowledge of HIV/AIDS
decreased from 50% in 2006 to 40% in 2016 (Zheng, 2020). Results showed that less students

were being adequately educated on HIV/AIDS health in 2016; for example, most students in the
survey knew that having one sexual partner reduced their risk of HIV transmission, but many
students still thought that a person can get HIV from a mosquito bite. Based on this, it is clear
that more emphasis needs to be put back into the education of college students. It’s important
that the Chinese government recognize that the main way that students in Beijing receive
information now is through social media, so there should be more effort put into reaching young
adults through this avenue.
A study done in the Arabian Peninsula also quantified education and knowledge of
HIV/AIDS, as well as attitudes toward the virus. The results were slightly surprising: 74.4% of
participants demonstrated adequate knowledge about HIV/AIDS, but more than half also
displayed negative attitudes towards HIV/AIDS (Aldhaleei, 2020). The findings about attitude
put into question the quality of education people in the Arabian Peninsula are receiving about
HIV. There may certainly be elements of cultural taboos that are associated with HIV/AIDS. For
instance, the study describes how college students in Saudi Arabia believe that HIV is a
punishment from God. Because many in the Arabian Peninsula are devoutly religious and share
beliefs similar to the students from Saudi Arabia, the education in this area needs to focus on
better understanding the disease, and drawing a clear line between HIV and religion. In this way,
attitudes about HIV/AIDS can be improved and stigma surrounding the virus can begin to lessen.
A similar study examined governmental HIV/AIDS programs in the Jayawijaya district
of Indonesia. The study showed that the current community empowerment in the implementation
of the HIV/AIDS prevention program in the Jayawijaya district is the involvement of
non-governmental organizations (Resubuna, 2019). The community was seemingly not involved
at all in the HIV/AIDS program planning process. This makes it extremely difficult to track

community members with HIV/AIDS, and many who are initially recognized as having
HIV/AIDS are lost to follow-up by the program because community leaders as well as religious
leaders are not involved. For patient retention of treatment to be increased, the government must
consider involving the community more in their programs. It is clear from these results that the
government in Indonesia puts little effort into improving their HIV/AIDS prevention programs.
In order for HIV prevention to be increased in the community, more effort needs to be put into
community empowerment in this area.
In Pakistan, a study aimed to assess the quality of life of people in the country living with
HIV. Results showed that more than half of participants reported being extremely anxious or
depressed (Ahmed, 2021). However, there was a significant correlation between ART adherence
and quality of life. The study found that people living with HIV/AIDS in Pakistan who were very
adherent to their antiretroviral therapy had a good overall quality of life, although still higher
depression than people without HIV/AIDS. Similar to the Arabian Peninsula, sociocultural
taboos about HIV are very popular. Therefore, more education, particularly psychological
education, needs to happen to decrease negative attitudes towards the virus and encourage
adherence to ART.
A trend seen in Asia is negative attitudes towards HIV/AIDS and ART that stems from
lack of education and cultural mores. However, HIV rates in Europe are high as well; it was
ranked second in new infections in 2020 by the World Health Organization. A study on
HIV/AIDS in Europe explains that infection varies significantly across regions in Europe, and
reflects a shifting and increasingly divided political landscape (Rosengarten, 2020). In Germany,
many HIV incidences come from prisons, where prisoners are not often seen as deserving
patients and are therefore not provided with clean needles or syringes or even condoms. In

Turkey, problems with HIV stem from refugees who, once again, do not seem to be as deserving
of proper healthcare as other citizens of Turkey. In Europe, it seems that HIV/AIDS incidence is
associated with citizenship status and that citizenship is indeed defined differently depending on
the country.
HIV/AIDS in South America is significantly different from Asia and Europe, and lessons
can be learned from how the region is handling the epidemic. Despite its large population, Brazil
is among the leading countries towards achieving UNAIDS’ goals for HIV/AIDS (Benzaken,
2019). When Brazil was first hit with the pandemic in the 1980s, the country responded by
offering free antiretroviral therapy (ART) to all people living with HIV. Brazil’s decision to treat
all people with HIV, regardless of CD4+ T cell count has also contributed to their drop in
AIDS-related deaths. Brazil also has universal and free-of-charge public health care. In the
context of HIV/AIDS, this vastly helps patients receive the drugs they need as well as adhere
well to them. However, this universally free health system for HIV/AIDS may be unsustainable
long-term, as antiretroviral drugs are expensive. This highlights the need for treatment besides
ARVs, such as a vaccine. As mentioned earlier, vaccine trials are still in the works, but Brazil is
at the forefront of research and will no doubt continue to benefit from their role in HIV
treatment.
HIV in Africa: A Humanitarian Crisis
None of the regions described above compare with the amount of HIV and AIDS in
Africa, particularly the sub-Saharan region. The HIV/AIDS crisis in Africa can truly be
described as a humanitarian crisis, as the virus has continued to run rampant in the region for
nearly 40 years, and ultimately reveals the complex nature of the deficiencies in the health sector
and in the HIV/AIDS related care programs in many countries. An article by a priest in Nigeria

challenges the responsibility of care within institutional structures, and how the victims of
HIV/AIDS do not receive the justice they deserve (Umunna, 2010). People living with
HIV/AIDS in African countries often face a scarcity of antiretroviral drugs, stigmatization,
discrimination, and lack of adequate care and support. Their very dignity as humans deserving of
fair treatment is ignored as HIV positive people face rejection from local communities and
institutions. There is a vast need in Africa for equal access to education and health care to be
guaranteed to all social groups, especially to young women.
In countries across Africa, young women have been the primary victims of HIV and
AIDS. This is a consequence of disparities in sexual relationships and marriages and the
traditional patriarchal societies that are common in African countries, as well as trends in sexual
violence among many communities. A study done in South Sudan assessed women’s knowledge
and attitudes about HIV, with only 21% of women having adequate knowledge and positive
attitudes towards people with HIV/AIDS (Mude, 2020). Knowledge and attitudes were found to
largely be shaped by differing levels of poverty, education, and different geographical settings. It
was also found that HIV interventions that were provided to South Sudan were
disproportionately delivered to urban and educated populations. Therefore, great strides need to
be taken in removing gender-based health inequities and protecting the rights of those at most
risk for contracting HIV. Interventions must be targeted to the uneducated women in rural areas.
Only when education is available to all women will there be a more significant decrease in
HIV/AIDS deaths in Africa.
A similar study done in Ghana compared the experiences of men living with HIV and
women living with HIV in the country. Unsurprisingly, there were significant differences
between the two experiences. Women were more likely to be housing insecure, unemployed, less

likely to have revealed their HIV status to family members, and had more challenges regarding
their healthcare (Owusu, 2020). The women were also mostly single and living in near-abject
poverty. Conversely, men living with HIV usually expected, demanded, and had support from
their wives. Almost every experience of men was opposite to that of the women. This once again
highlights the vital need for policies to focus on women. The current system does not give
women living with HIV the social protection they need and deserve, and if public education were
to highlight the extra burden of HIV/AIDS on women, the public may be more inclined to
empathize with them instead of allowing them to suffer in silence.
A study done in rural communities in Uganda and Kenya examined the method with
which HIV testing and treatment was carried out. They postulated that universal HIV treatment
would lower incidence of HIV infection, and found that viral suppression was indeed higher in
groups that received this universal care than those that received standard care (Havlir, 2019). The
annual incidence of HIV infection also decreased by 32% over the 3 years that the study took
place. This shows that the way in which care is delivered is important to clinical outcomes. As
was evidenced from Brazil’s approach to caring for people with HIV/AIDS, a universal and
patient-centered approach to HIV treatment seems to result in a lower number of new HIV
infections and better overall health.
It is clear that countries in Africa are suffering under the burden of HIV/AIDS. Lack of
health care and social attitudes contribute to high rates of AIDS-related deaths. One study that
examined global trends in HIV/AIDS found an association between GDP per capita of countries
and incidence of HIV/AIDS (Baghaei Lakeh, 2017). In addition, more affluent countries publish
more biomedical papers on HIV/AIDS research, which in turn lends these countries to have a
better understanding of the virus. Around half of the world’s people who live in extreme poverty

live in sub-Saharan Africa, so HIV testing and treatment as well as general understanding of HIV
is scarce. There are widespread consequences to this humanitarian crisis. The average life
expectancy in Africa is decreasing as the number of orphans due to AIDS deaths is increasing.
This in turn leads to loss of labor, which decreases the economic growth of African countries.
Therefore, not only is the AIDS crisis in Africa an issue of ethics and social justice, it has so
affected the region that it has turned into an economic and political problem as well. More
attention must be put into improving HIV education, testing, and treatment, particularly among
women.
Social Attitudes about HIV/AIDS
Effects of Stigma on the HIV-Positive Individual
Stigma against the HIV-positive individual exists for a number of reasons. HIV is largely
associated with marginalized groups of people: minorities, members of the LGBTQ+ community,
and people who use injection drugs. A study sought to examine how people living with HIV
respond to this stigma in their communities. The results found significant associations between
perceived community stigma and interpersonal outcomes (such as social support and trust in
physicians) were mediated by internalized stigma and anticipated stigma (Turan, 2016). Thus,
HIV-related stigma in communities seems to cause people with HIV to internalize and anticipate
stigma. This results in negative health and psychosocial consequences. These consequences can
include subpar medication adherence, higher depression, and lower quality of life altogether.
Based on these results, a change is needed in communities to decrease stigma and empower
HIV-positive individuals. It may also be helpful to better treat depression and other mental health
issues among people living with HIV. By treating the psychosocial health of these individuals,
adherence is consequently increased, resulting in better physical health as well.

Another study focused specifically on transgender women, of which one-fifth are living
with HIV. Transgender individuals with HIV face sigificantly more discrimination than cisgender
people with HIV, and thus often have a difficult time accessing HIV care. It was found that
transgender women receiving HIV care were more likely to identify as a racial minority and less
likely to have stable housing than cisgender individuals (Klein, 2020). In particular, black
transgender women were much less likely to reach viral suppression than any other group of
people. This highlights the need for HIV care to be widely available to every person living with
HIV, regardless of gender, race, or sexual orientation. In the past, HIV treatment operated under
the assumption that transgender women and cisgender men who have sex with men had the same
risk factors and could be reached in the same way. However, this study shows that
transgender-specific outreach is needed, as the disparities in viral suppression between these two
groups are great.
Stigma and discrimination against HIV has become so engrained in society that even
people who are simply associated with HIV/AIDS even face stigma. These are the nurses,
physicians, and other healthcare workers who help to care for HIV-positive patients. The
unfounded fear that HIV infection can occur from merely interacting with someone who is
HIV-positive causes barriers to healthcare workers who would seek preventative treatment for a
needle-stick injury or early diagnosis (Hewko, 2018). Workplace policies and quality assurance
initiatives targeted at HIV/AIDS stigma are warranted to reduce incidence of HIV/AIDS in
healthcare workers and encourage new innovations in HIV/AIDS treatment. Currently, there are
major gaps in workplace policies when it comes to HIV/AIDS. Interventions need to be
organization-wide and explicit in targeting HIV/AIDS stigma. People living with HIV should not

have to deal with the stigma that comes along with the virus, and the workers providing care for
the patients should especially be saved from discrimination based on misinformation.
Perceptions and Representations of People Living with HIV
Those in high school and young adults are some of the population at the most risk for
contracting HIV. Young people with HIV often have difficulty adhering to treatment, so it is
important that prevention from HIV and other STIs is taught early. A study on high school
students’ perceptions and representations about HIV/AIDS consisted of the terms “condom,
disease, prevention, and sex” (de Amorim Barreto, 2019). Therefore, although they may not
know many of the specifics about HIV, they know that they can use condoms to prevent its
transmission, same as most other STIs. However, there is still fear of social exclusion that is
associated with HIV, so if a student is HIV-positive, they are less likely to reveal their serostatus,
putting them at very high risk of transmitting the virus. The dialogue about using condoms is a
good start to having an open dialogue about safe sexual practices, but schools also need to make
sure to emphasize the idea that there is not shame surrounding HIV status.
As young adults leave high school, they begin in engaging in more high risk behaviors
that put them at greater risk of HIV infection. Adults in their late teens and early twenties
makeup more than one-fourth of new infections in the U.S., and behaviors such as alcohol use as
an HIV-positive individual tend to accelerate HIV disease progression. This population also has
low rates of ART adherence. To improve these behaviors, a study was done using an intervention
for HIV-positive young adults called Healthy Choices. The intervention consisted of in-depth
discussions with the individuals and personal motivational interviews, as well as guiding the
development of individualized plans of action to reduce unhealthy behaviors. The study found
that, after a year of the Healthy Choices intervention, 35% of participants had an undetectable

viral load (Naar, 2020). This came as a result of a decrease in high-risk behaviors such as alcohol
consumption. This gives an idea of the direction that HIV interventions should be heading in the
future to continue to suppress viral loads. A clinic-based intervention that focuses on motivation
and individualized goals seem to be the best course of action when encouraging young adults
living with HIV.
Another group at extremely high risk for spreading HIV is sex workers. Many sex
workers engage in sexual activities with clients without using protection, putting them at even
greater risk for spreading HIV, not to mention numerous other STIs. Sex workers cite the
dilemma of needing to use sex as a source of livelihood and clients who prefer not to use
protection. A study that analyzed the HIV/AIDS knowledge of sex workers found that 72.2% of
sex workers engaged in intercourse with clients without protection in exchange for a larger
amount of money, while at the same time 61.7% of workers had adequate knowledge about HIV
(Freire de Araújo Patrício, 2019). These are curious statistics, as one might assume that if a sex
worker has adequate knowledge of HIV that they will do what they can to prevent it. However, it
is worth mentioning that for many of these sex workers, sex is their only means of income for
their survival, and they will do what they can if they can earn more. This is a difficult problem to
solve, as it ultimately traces back to the unequal power dynamic between men and women.
Female sex workers know the risks, but feel that they cannot deny a client his wishes of not
using protection, especially if he is paying extra. It’s unclear if more HIV education for sex
workers would lessen HIV transmission in this group. It’s possible that teaching female sex
workers how to negotiate with clients to use protection may help, but ultimately that still leaves a
very large burden on the backs of these sex workers. It’s important that clients who visit these

establishments are aware of the risks to not only themselves, but to sex workers and any other
sexual partners they have if they don’t use protection.
The Changing World of HIV/AIDS
Current Trends in Testing and Treatment
To understand the treatments that have developed for HIV, one must first understand the
basic mechanism by which HIV works in the body. There are two types of HIV infections: HIV-1
and HIV-2. HIV-1 is what is most widely known by people, as it is aggressive and can lead to
AIDS if untreated. HIV-2 is similar, but is less aggressive and mostly contained to Western
Africa. Contrary to popular belief, the major route of HIV transmission is through heterosexual
contact. However HIV can also be transmitted parenterally or perinatally. After infection, HIV
can be detected in plasma by nucleic acid amplification of viral RNA or by detection of the viral
core protein p24 (Melhuish, 2018). Four to six weeks later, antibodies are detectable. After three
months, seroconversion occurs and the person with the infection is officially HIV
antibody-positive. Initially, high levels of circulating virus cause symptoms in the patient (this is
called seroconversion illness), but the patient becomes asymptomatic for a few years when viral
levels decline, although the virus still remains. CD4+ T cell levels decline from the viral killing,
causing decreased immune response. People with HIV will often speak of their T cell count,
which serves as an indication of their viral load, or how much virus is in the body.
Antiretroviral therapy (ART) is the most common treatment for HIV that has been used
since the late 90s, but ART is not a cure for HIV; rather, it helps to keep viral load low and T cell
count high enough to function and live a full life. There are also issues with ART, such as cost
and toxicity. One study sought to examine some of the newer approaches towards a cure for
HIV/AIDS. Problems with trying to treat HIV include dealing with the latent viral reservoir,

boosting the host immune response, and reaching relevant viral compartments in the body
(Bailon, 2020). The ultimate goal with HIV treatment is to achieve viral control without the need
for antiretroviral treatment. Researchers have begun to identify agents that can reactivate the
latent virus in vivo and boost cellular and humoral immunity. Of particular interest are broadly
neutralizing antibodies, or bNAbs, which so far have been able to stop HIV from infecting
human cells in the laboratory. Not many people with HIV naturally produce bNAbs, but
researchers have been able to isolate them from the blood of people with HIV. Other treatments
such as vaccines have also been tested, but so far with little evidence of significant effectiveness.
ART has been able to greatly increase the life expectancy of people with HIV. However,
treatment has not yet reached the point where individuals with HIV have the same life
expectancy as people without HIV. A study comparing the comorbidity-free life expectancies
between adults with and without HIV lived 6.8 fewer years overall and 9.5 fewer years without
major chronic comorbidities (Marcus, 2020). Thus, although the life spans are similar, people
living with HIV are more likely to have other health problems in their life. The
immunodeficiency of HIV-positive individuals means that they are more susceptible to
comorbidities such as cancer and cardiovascular disease. Furthermore, ART is known to be toxic
and can contribute to diabetes, kidney and liver disease, and high cholesterol, among other
things. This is just one reason why it is important for new treatments for HIV to be investigated.
Treatments besides ART may have the ability to decrease some of the comorbidities suffered by
HIV-positive individuals.
Another common HIV treatment is pre-exposure prophylaxis, commonly known as PrEP.
PrEP involves the use of daily or event-based antiretroviral drugs to reduce the risk of HIV
infection. PrEP has been most popular among men who have sex with men (MSM), who are at

high risk of acquiring the virus. There are challenges in providing optimal PrEP services for
MSM. There is a need for more positive therapeutic alliance between the patient and the
prescriber in supporting adherence to PrEP regimens, as well as a need for PrEP availability
through different methods of delivery to the MSM community (Hillis, 2020). Young MSM who
are also racial minorities are far less likely to be seeking HIV testing, diagnosis, or treatment.
Therefore, special care needs to be put into providing these groups most at risk with the services
that they need. PrEP is a vital treatment for individuals who are not HIV-positive but engage in
high risk behaviors, and it is important that this group adheres to the regimen. Otherwise, there
could be many more positive HIV diagnoses in the future.
In order to identify the need for treatment with PrEP and ART, there first needs to be
adequate testing. One way to reduce incidence of HIV infection is universal testing and
treatment. Universal testing and treatment has been found to reduce population-level incidence
of HIV infection by around 30% (Hayes, 2019). Prevention intervention with universal ART
includes utilizing home-based HIV testing delivered by community workers and also
home-based HIV care and ART adherence. Testing and HIV care that was delivered in this way
resulted in more viral suppression and better adherence to medication. This is especially
important in reaching young people and minorities, who are often neglected when it comes to
HIV care. Early and frequent testing leads to better prevention and ultimately lower incidence of
the virus.
The Future of HIV/AIDS Treatment
HIV/AIDS has come a long way since the 1980s, both in medical treatment and social
attitudes. With new advancements in science and technology everyday, the future of HIV/AIDS
can remain hopeful. Ultimately, a safe and efficacious HIV vaccine would be the most ideal

treatment for the virus, although so far there has been no significant success in investigating this
treatment. A relatively new method for investigating an HIV vaccine is becoming more popular:
the use of bioengineering approaches to modulate immune responses (D’Souza, 2019). For other
autoimmune disorders, regulating and controlling the immune system through the use of
engineered nucleic acids, proteins, biomaterials, cells, and tissues has been promising. The
National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of
Biomedical Imaging and Bioengineering have begun combining efforts to expand and facilitate
the adaptation of engineering principles and techniques into the design of a possible vaccine. It is
the hope that these new strategies will translate well to a clinical setting.
With new strategies and hope, the Joint United Nations Programme on HIV/AIDS
(UNAIDS) announced a bold plan in 2019 to end the HIV epidemic in the U.S. by 2030. For this
to happen, the number of new HIV infections and AIDS-related deaths would need to decrease
by 90% between 2010 and 2030 (Assefa, 2020). The World Health Organization also cited a
90-90-90 target by 2020: 90% of people living with HIV know their HIV status, 90% of people
who know their HIV-positive status are accessing treatment, and 90% of people on treatment
have suppressed viral loads. As optimistic as these plans are, unfortunately they are not so
realistic. Although incidences of new HIV infections continue to decline, the progress is slower
than is required to reach the 2030 goal. Project 2030 can get back on track if focus stays on
preventing and diagnosing infection, linking people to care, and providing ART. HIV will not go
away after 2030, and HIV prevention and control programs must remain robust.
Conclusion
Looking at the many setbacks in the world of HIV/AIDS can make the future for
HIV-positive individuals and those at risk look disheartening. The unsuccessful vaccine, the

failure of the 2030 plan, and the continued issue of HIV/AIDS in Africa are all problems that still
need to be fixed. However, it is important to remain positive and hopeful about where the future
of HIV/AIDS will take us. Science is evolving everyday, and although the first couple vaccine
trials have not yet shown success, there are so many trials that are still in progress. And now
more than ever, social acceptance and normalization of HIV-positive individuals is on the rise.
Celebrities are now using their platforms to spread awareness of the virus and banish the shame
that used to be associated with a positive HIV infection.
As hope and positivity are spread around the United States, it is important to remember
those that do not have the luxury to be hopeful about HIV. The devastating HIV crisis in Africa
continues to be far worse than any other continent, and will most likely remain this way. Stories
of young women and children in rural parts of Africa having the virus violently forced upon
them should remind us that, although not as many people are dying of AIDS in America, AIDS
deaths are extremely prevalent in sub-Saharan countries and these rural communities need a cure
more than anyone. So much attention has been put on preventing HIV that it seems like a true
cure might never happen. Many articles on the topic of HIV/AIDS warn that there is too much of
a “biological” approach to a cure for HIV and not enough personal and individualized
approaches. But maybe now the opposite is true. HIV is such a complex virus that more efforts
need to be put into studying its mechanisms. For the time being, PrEP and ART are keeping the
virus at bay. Now, let us continue the research necessary to completely eradicate HIV once and
for all.
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